Molekule Group, Inc. Price & Performance (MKUL)

Merck posted $15.5 billion in first-quarter 2025 sales, down 2% year-over-year, with KEYTRUDA revenues rising 4% to $7.2 billion. The company updated its full-year outlook and highlighted new licensing deals and positive late-stage trial data, aiming to offset declines in other product lines and ongoing tariff-related costs.12

Buhler Industries’ board has recommended minority shareholders accept a $7.30 per share offer as part of an amalgamation proposal. A formal PwC valuation found the share price fair, valuing shares between $7.15 and $7.83. The special committee determined the deal is in shareholders’ best interests.34

Kubota’s stock dipped below its 200-day moving average, trading at $56.89. The company, with a $13.14 billion market cap, recently saw its analyst rating upgraded from 'strong sell' to 'hold.' Despite a solid earnings report, analysts suggest better opportunities may exist elsewhere in the sector.56